Literature DB >> 8836146

An investigation of the mechanism of inhibition of the Ca(2+)-ATPase by phospholamban.

G Hughes1, A P Starling, R P Sharma, J M East, A G Lee.   

Abstract

The Ca(2+)-ATPase of skeletal muscle sarcoplasmic reticulum has been reconstituted with peptides corresponding to the hydrophobic domain of phospholamban (PLB) with or without the three Cys residues replaced by Ala, and with PLB with the three Cys residues replaced by Ala [PLBcys-(1-52)]. Reconstitution with the hydrophobic domain of PLB[PLB(25-52)] was found to decrease the apparent affinity of the ATPase for Ca2+ with no effect on the maximal rate of ATP hydrolysis observed at saturating concentrations of Ca2+. Reconstitution with PLBCys-(1-52) decreased both the apparent affinity for Ca2+ and the maximal activity; the effect on maximal activity followed from a decrease in the rate of the Ca2+ transport step (E1PCa2-->E2P) as observed with the hydrophilic domain PLB(1-25). The concentration dependences of the effects of the hydrophobic domain and of the whole PLB molecule were very similar, suggesting that the hydrophilic domain made little contribution to the affinity of the ATPase for PLB. The effect of PLB on the ATPase was dependent on the molar ratio of phospholipid to ATPase, suggesting partition of the PLB between its binding site on the ATPase and the bulk lipid phase in the membrane. Neither PLB nor its hydrophobic domain affected the rates of phosphorylation or dephosphorylation of the ATPase. Despite their effects on the apparent affinity of the ATPase for Ca2+, neither PLB nor its hydrophobic domain had any effect on the true affinity of the ATPase for Ca2+, as measured from changes in the tryptophan fluorescence of the ATPase. The effects of PLB on the activity of the ATPase are the sum of the effects of its hydrophilic and hydrophobic domains.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8836146      PMCID: PMC1217713          DOI: 10.1042/bj3180973

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

1.  Structural model of the phospholamban ion channel complex in phospholipid membranes.

Authors:  I T Arkin; M Rothman; C F Ludlam; S Aimoto; D M Engelman; K J Rothschild; S O Smith
Journal:  J Mol Biol       Date:  1995-05-12       Impact factor: 5.469

2.  Mechanism of inhibition of Ca(2+)-ATPase by myotoxin a.

Authors:  K J Baker; J M East; A G Lee
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

3.  Functional reconstitution of recombinant phospholamban with rabbit skeletal Ca(2+)-ATPase.

Authors:  L G Reddy; L R Jones; S E Cala; J J O'Brian; S A Tatulian; D L Stokes
Journal:  J Biol Chem       Date:  1995-04-21       Impact factor: 5.157

4.  Solution structure of the cytoplasmic domain of phopholamban: phosphorylation leads to a local perturbation in secondary structure.

Authors:  R J Mortishire-Smith; S M Pitzenberger; C J Burke; C R Middaugh; V M Garsky; R G Johnson
Journal:  Biochemistry       Date:  1995-06-13       Impact factor: 3.162

5.  Mechanism of inhibition of the Ca(2+)-ATPase by melittin.

Authors:  K J Baker; J M East; A G Lee
Journal:  Biochemistry       Date:  1995-03-21       Impact factor: 3.162

6.  Lumenal and cytoplasmic binding sites for calcium on the calcium ATPase of sarcoplasmic reticulum are different and independent.

Authors:  J Myung; W P Jencks
Journal:  Biochemistry       Date:  1994-07-26       Impact factor: 3.162

7.  Secondary structure and orientation of phospholamban reconstituted in supported bilayers from polarized attenuated total reflection FTIR spectroscopy.

Authors:  S A Tatulian; L R Jones; L G Reddy; D L Stokes; L K Tamm
Journal:  Biochemistry       Date:  1995-04-04       Impact factor: 3.162

8.  The hydrophilic domain of phospholamban inhibits the Ca2+ transport step of the Ca(2+)-ATPase.

Authors:  G Hughes; J M East; A G Lee
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

9.  Expression of phospholamban in C2C12 cells and regulation of endogenous SERCA1 activity.

Authors:  J M Harrer; S Ponniah; D G Ferguson; E G Kranias
Journal:  Mol Cell Biochem       Date:  1995-05-10       Impact factor: 3.396

10.  Calcium-activated tension of skinned muscle fibers of the frog. Dependence on magnesium adenosine triphosphate concentration.

Authors:  R E Godt
Journal:  J Gen Physiol       Date:  1974-06       Impact factor: 4.086

View more
  9 in total

Review 1.  What the structure of a calcium pump tells us about its mechanism.

Authors:  A G Lee; J M East
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

2.  Cytoplasmic interactions between phospholamban residues 1-20 and the calcium-activated ATPase of the sarcoplasmic reticulum.

Authors:  P Sharma; V B Patchell; Y Gao; J S Evans; B A Levine
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

3.  Epigallocatechin-3-gallate has dual, independent effects on the cardiac sarcoplasmic reticulum/endoplasmic reticulum Ca2+ ATPase.

Authors:  M E Kargacin; T L Emmett; Gary J Kargacin
Journal:  J Muscle Res Cell Motil       Date:  2011-08-05       Impact factor: 2.698

4.  Anti-phospholamban and protein kinase A alter the Ca2+ sensitivity and maximum velocity of Ca2+ uptake by the cardiac sarcoplasmic reticulum.

Authors:  M E Kargacin; Z Ali; G Kargacin
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

5.  Structure of the 1-36 amino-terminal fragment of human phospholamban by nuclear magnetic resonance and modeling of the phospholamban pentamer.

Authors:  P Pollesello; A Annila; M Ovaska
Journal:  Biophys J       Date:  1999-04       Impact factor: 4.033

6.  Sarcolipin uncouples hydrolysis of ATP from accumulation of Ca2+ by the Ca2+-ATPase of skeletal-muscle sarcoplasmic reticulum.

Authors:  Wendy S Smith; Robert Broadbridge; J Malcolm East; Anthony G Lee
Journal:  Biochem J       Date:  2002-01-15       Impact factor: 3.857

7.  Sarcolipin protein interaction with sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA) is distinct from phospholamban protein, and only sarcolipin can promote uncoupling of the SERCA pump.

Authors:  Sanjaya K Sahoo; Sana A Shaikh; Danesh H Sopariwala; Naresh C Bal; Muthu Periasamy
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

8.  Alzheimer's disease: A hypothesis on pathogenesis.

Authors:  D Harman
Journal:  J Am Aging Assoc       Date:  2000-07

9.  Comparison of the structure and function of phospholamban and the arginine-14 deficient mutant associated with dilated cardiomyopathy.

Authors:  Eleri Hughes; David A Middleton
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.